Hee Jong Lee, Kyo Sang Kim^*, Ji Seon Jeong, Sung Hwan Choi, Kyu Nam Kim

Show more
Department of Anesthesiology and Pain Medicine, Hanyang University Hospital, Seoul, South Korea.
Show less

Abstract: Anticholinesterase does not allow adequate reversal of the deep neuromuscular blockade (NMB) achieved using high doses of relaxants. A 71-year-old female patient (weight 70 kg, height 169 cm) was scheduled for a transurethral resection of a bladder tumor under general anesthesia. We administered rocuronium 30 mg (0.43 mg/kg) for tracheal intubation due to an estimated short surgical time. During the operation, an additional rocuronium 10 mg was injected. The surgical procedure ended abruptly 10 minutes after receiving the last dose of rocuronium. At the end of surgery, the patient received pyridostigmine as a reversal. However, residual NMB persisted, and neuromuscular monitoring did not show the expected degree of recovery. Sugammadex 2 mg/kg was used, and the patient experienced complete reversal from NMB in just 2 min.

Keywords: Pyridostigmine; Residual Block; Rocuronium; Sugammadex

Cite this paper: H. Lee, K. Kim, J. Jeong, S. Choi and K. Kim, "Effective Use of Sugammadex for Incomplete Pyridostigmine Reversal of Muscle Relaxation by Rocuronium: A Case Report," Open Journal of Anesthesiology, Vol. 3 No. 9, 2013, pp. 393-395. doi: 10.4236/ojanes.2013.39083.

References

[1]   G. S. Murphy, J. W. Szokol, J. M. Marymont, et al., “Residual Paralysis at the Time of Tracheal Extubation,” Anesthesia & Analgesia, Vol. 100, No. 6, 2005, pp. 1840-1845.
http://dx.doi.org/10.1213/01.ANE.0000151159.55655.CB

[2]   S.-J. Jeong, J.-I. Han, H.-J. Baik, H. Lee, et al., “The Effect of Pyridostigmine on Bispectral Index during Recovery from Sevoflurane Anesthesia,” Korean Journal of Anesthesiology, Vol. 61, No. 6, 2011, pp. 460-464.
http://dx.doi.org/10.4097/kjae.2011.61.6.460

[3]   R. D. Miller, L. S. Van Nyhuis, E. I. Eger 2nd, et al., “Comparative Times to Peak Effect and Durations of Action of Neostigmine and Pyridostigmine,” Anesthesiology, Vol. 41, No. 1, 1974, pp. 27-33.

[4]   K. S. Kim, S. H. Lew, H. Y. Cho, et al., “Residual Paralysis Induced by Either Vecuronium or Rocuronium after Reversal with Pyridostigmine,” Anesthesia & Analgesia, Vol. 95, No. 6, 2002, pp. 1656-1660.

[5]   R. K. Mirakhur. “Sugammadex in Clinical Practice,” Anaesthesia, Vol. 64, Suppl. 1, 2009, pp. 45-54.
http://dx.doi.org/10.1111/j.1365-2044.2008.05870.x

[6]   A. F. Kopman, S. Kumar, M. M. Klewicka, et al., “The Staircase Phenomenon. Implications for Monitoring of Neuromuscular Transmission,” Anesthesiology, Vol. 95, No. 2, 2001, pp. 403-407.

[7]   R. S. Matteo, E. Ornstein, A. E. Schwartz, et al., “Pharmacokinetics and Pharmacodynamics of Rocuronium (Org 9426) in Elderly Surgical Patients,” Anesthesia & Analgesia, Vol. 77, No. 6, 1993, pp. 1193-1197.

[8]   A. Ferguson, P. Egerszegi, D. R. Bevan, et al., “Neostigmine, Pyridostigmine, and Edrophonium as Antagonists of Pancuronium,” Anesthesiology, Vol. 53. No. 5, 1980, pp. 390-394.

[9]   F. Donati, J. Lahoud, D. McCready, et al., “Neostigmine, Pyridostigmine and Edrophonium and Neostigmine as Antagonists of Deep Pancuronium Blockade,” Canadian Journal of Anaesthesia, Vol. 34, No. 6, 1987, pp. 589-593.

[10]   A. Y. Oh, S. D. Kim and C. S. Kim, “Early and Late Reversal of Rocuronium with Pyridostigmine during Sevoflurane Anaesthesia in Children,” Anaesthesia and Intensive Care, Vol. 32, No. 5, 2004, pp. 649-652.

[11]   S. J. Jeong, J. I. Han, H. J. Baik, et al., “The Effect of Pyridostigmine on Bispectral Index during Recovery from Sevoflurane Anesthesia,” Korean Journal of Anesthesiology, Vol. 61, No. 6, 2011, pp. 460-464.
http://dx.doi.org/10.4097/kjae.2011.61.6.460

[12]   A. Abrishami, J. Ho, J. Wong, et al., “Cochrane Corner: Sugammadex, a Selective Reversal Medication for Preventing Postoperative Residual Neuromuscular Blockade,” Anesthesia & Analgesia, Vol. 110, No. 4, 2010, p. 1239.

[13]   S. B. Groudine, R. Soto, C. Lien, et al., “A Randomized, Dose-Finding, Phase II Study of the Selective Relaxant Binding Drug, Sugammadex, Capable of Safely Reversing Profound Rocuronium-Induced Neuromuscular Block,” Anesthesia & Analgesia, Vol. 104, No. 3, 2007, pp. 555-562.
http://dx.doi.org/10.1213/01.ane.0000260135.46070.c3

[14]   M. Blobner, L. I. Eriksson, J. Scholz, et al., “Reversal of Rocuronium-Induced Neuromuscular Blockade with Sugammadex Compared with Neostigmine during Sevoflurane Anaesthesia: Results of a Randomised, Controlled Trial,” European Journal of Anaesthesiology, Vol. 27. No. 10, 2010, pp. 874-881.
http://dx.doi.org/10.1097/EJA.0b013e32833d56b7

[15]   F. Paton, M. Paulden, D. Chambers, et al., “Sugammadex Compared with Neostigmine/Glycopyrrolate for Routine Reversal of Neuromuscular Block: A Systematic Review and Economic Evaluation,” British Journal of Anaesthesia, Vol. 105, No. 5, 2010, pp. 558-567.
http://dx.doi.org/10.1093/bja/aeq269